Pulse Biosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
Pulse Biosciences, Inc. (PLSE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $6.70 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2021-03-12
- Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2020 was $6.70M, a 20.24% decline from fiscal 2019.
- Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2019 was $8.40M, a 31.25% increase from fiscal 2018.
- Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2018 was $6.40M, a 76.12% decline from fiscal 2017.
- Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2017 was $26.80M, a 2133.33% increase from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|
| 2020-12-31 | $6.70M 10-K · filed 2021-03-12 |
| 2019-12-31 | $8.40M 10-K · filed 2021-03-12 |
| 2018-12-31 | $6.40M 10-K · filed 2021-03-12 |
| 2017-12-31 | $26.80M 10-K · filed 2020-03-16 |
| 2016-12-31 | $1.20M 10-K · filed 2019-03-14 |
| 2015-12-31 | $3.10M 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |